Greetings from MyCancerHaven!

We wanted to update you on our recent activities.

Here are the latest posts last week:

‍Blogs :

‍Dr. Bhat Weighs Liso-Cel vs Pirtobrutinib for Relapsed/Refractory CLL

‍Dr. Ghia Compares CLL OS on Ibrutinib/Venetoclax to Healthy Population

‍Dr. Jain Addresses Challenges in Defining Venetoclax Failure in CLL Patients
‍
‍Also at MCH the News and Tweets never stop flowing!

Join Us at www.mycancerhaven.org

‍The Team @ MCH

Follow us on Facebook, Twitter (@My_Cancer_Haven), Instagram, YouTube, LinkedIn and TikTok

Note: Please do not reply to this e-mail as it is sent from an account that is not monitored. You can contact us by e-mail at contact@mycancerhaven.org.